The Diagnostic Yield of Intellectual Disability: Combined Whole Genome Low-coverage Sequencing and Medical Exome Sequencing

Overview

Journal BMC Med Genomics

Publisher Biomed Central

Specialty Genetics

Date 2020 May 21

PMID 32429945

Citations 15

Authors

Jun Wang

Yan Wang

Liwen Wang

Wang Yang Chen

Min Sheng

Affiliations

Soon will be listed here.

Abstract

Background: Intellectual disability (ID) is a heterogeneous neurodevelopmental disorder with a complex genetic underpinning in its etiology. Chromosome microarray (CMA) is recommended as the first-tier diagnostic test for ID due to high detection rate of copy number variation (CNV).

Methods: To identify an appropriate clinical detection scheme for ID in Han Chinese patients, whole genome low-coverage sequencing was performed as the first-tier diagnostic test, and medical exome sequencing (MES) as the second-tier diagnostic test for patients with negative results of CNVs.

Results: A total of 19 pathogenic CNVs in 16/95(16.84%) ID patients and 10 pathogenic single-nucleotide variations (SNVs), including 6 novel mutations in 8/95(8.42%) ID patients were identified on whom no pathogenic CNVs were discovered. The detection rate of CNVs in ID with multiple congenital anomalies (MCA) subgroup was significantly higher than ID with autism spectrum disorders and other IDs subgroups. And the single-nucleotide variations showed a higher occurrence rate in the other IDs subgroup.

Conclusions: There were differences in the diagnostic yields of different variation types among the three ID subgroups. Our findings provided a new perspective on appropriate clinical detection scheme in different ID subgroups based on statistically significant differences among the three ID subgroups. The application of whole genome low-coverage sequencing as the first-tier diagnostic test for ID with MCA subgroup and MES as the first-tier diagnostic test for other ID subgroup was considered as an efficient clinical detection scheme.

Citing Articles

Copy number variant analysis improves diagnostic yield in a diverse pediatric exome sequencing cohort.

Hahn E, Dharmadhikari A, Markowitz A, Estrine D, Quindipan C, Maggo S NPJ Genom Med. 2025; 10(1):16.

PMID: 39984494 PMC: 11845629. DOI: 10.1038/s41525-025-00478-4.

Molecular diagnosis of patients with syndromic short stature identified by trio whole-exome sequencing.

Sun H, Zhang G, Li N, Bu X Front Genet. 2024; 15:1399186.

PMID: 39415983 PMC: 11479978. DOI: 10.3389/fgene.2024.1399186.

PROs for RARE: protocol for development of a core patient reported outcome set for individuals with genetic intellectual disability.

van Silfhout N, van Muilekom M, van Karnebeek C, Haverman L, Van Eeghen A Orphanet J Rare Dis. 2024; 19(1):354.

PMID: 39334201 PMC: 11428331. DOI: 10.1186/s13023-024-03264-0.

CC2D1A causes ciliopathy, intellectual disability, heterotaxy, renal dysplasia, and abnormal CSF flow.

Kim A, Sakin I, Viviano S, Tuncel G, Aguilera S, Goles G Life Sci Alliance. 2024; 7(10).

PMID: 39168639 PMC: 11339347. DOI: 10.26508/lsa.202402708.

Navigating the outcome maze: a scoping review of outcomes and instruments in clinical trials in genetic neurodevelopmental disorders and intellectual disability.

Muller A, van Silfhout N, den Hollander B, Kampman D, Bakkum L, Brands M Ther Adv Rare Dis. 2024; 5:26330040241245721.

PMID: 38681798 PMC: 11047260. DOI: 10.1177/26330040241245721.

References

Wagenstaller J, Spranger S, Lorenz-Depiereux B, Kazmierczak B, Nathrath M, Wahl D . Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation. Am J Hum Genet. 2007; 81(4):768-79. PMC: 2227926. DOI: 10.1086/521274. View

Chiurazzi P, Pirozzi F . Advances in understanding - genetic basis of intellectual disability. F1000Res. 2016; 5. PMC: 4830215. DOI: 10.12688/f1000research.7134.1. View

Xie C, Tammi M . CNV-seq, a new method to detect copy number variation using high-throughput sequencing. BMC Bioinformatics. 2009; 10:80. PMC: 2667514. DOI: 10.1186/1471-2105-10-80. View

Ropers H . Genetics of intellectual disability. Curr Opin Genet Dev. 2008; 18(3):241-50. DOI: 10.1016/j.gde.2008.07.008. View

Gilissen C, Hehir-Kwa J, Tjwan Thung D, van de Vorst M, van Bon B, Willemsen M . Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014; 511(7509):344-7. DOI: 10.1038/nature13394. View

Clissold R, Ashfield B, Burrage J, Hannon E, Bingham C, Mill J . Genome-wide methylomic analysis in individuals with HNF1B intragenic mutation and 17q12 microdeletion. Clin Epigenetics. 2018; 10(1):97. PMC: 6052548. DOI: 10.1186/s13148-018-0530-z. View

Johansen A, Rosti R, Musaev D, Sticca E, Harripaul R, Zaki M . Mutations in MBOAT7, Encoding Lysophosphatidylinositol Acyltransferase I, Lead to Intellectual Disability Accompanied by Epilepsy and Autistic Features. Am J Hum Genet. 2016; 99(4):912-916. PMC: 5065650. DOI: 10.1016/j.ajhg.2016.07.019. View

Resta N, De Cosmo L, Susca F, Capodiferro D, Nardone A, Pastorivo D . De novo unbalanced translocation leading to monosomy 9p24.3p24.1 and trisomy 19q13.42q13.43 characterized by microarray-based comparative genomic hybridization in a child with partial cortical dysplasia and craniofacial dysmorphisms without.... Am J Med Genet A. 2013; 161A(3):632-6. DOI: 10.1002/ajmg.a.35777. View

Fan Y, Wu Y, Wang L, Wang Y, Gong Z, Qiu W . Chromosomal microarray analysis in developmental delay and intellectual disability with comorbid conditions. BMC Med Genomics. 2018; 11(1):49. PMC: 5968608. DOI: 10.1186/s12920-018-0368-4. View

10.

Martinez F, Caro-Llopis A, Rosello M, Oltra S, Mayo S, Monfort S . High diagnostic yield of syndromic intellectual disability by targeted next-generation sequencing. J Med Genet. 2016; 54(2):87-92. DOI: 10.1136/jmedgenet-2016-103964. View

11.

Capobianco S, Lava S, Bianchetti M, Martinet D, Belfiore M, Ramelli G . Chromosomal microarray among children with intellectual disability: a useful diagnostic tool for the clinical geneticist. Dev Med Child Neurol. 2013; 56(3):290. DOI: 10.1111/dmcn.12341. View

12.

Grozeva D, Carss K, Spasic-Boskovic O, Tejada M, Gecz J, Shaw M . Targeted Next-Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability. Hum Mutat. 2015; 36(12):1197-204. PMC: 4833192. DOI: 10.1002/humu.22901. View

13.

Nagamani S, Erez A, Shen J, Li C, Roeder E, Cox S . Clinical spectrum associated with recurrent genomic rearrangements in chromosome 17q12. Eur J Hum Genet. 2009; 18(3):278-84. PMC: 2987224. DOI: 10.1038/ejhg.2009.174. View

14.

Dong Z, Jiang L, Yang C, Hu H, Wang X, Chen H . A robust approach for blind detection of balanced chromosomal rearrangements with whole-genome low-coverage sequencing. Hum Mutat. 2014; 35(5):625-36. DOI: 10.1002/humu.22541. View

15.

Rauch A, Hoyer J, Guth S, Zweier C, Kraus C, Becker C . Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet A. 2006; 140(19):2063-74. DOI: 10.1002/ajmg.a.31416. View

16.

Kwon S, Kim J, Shin S, Lee S, Lee K, Choi J . Deletion of 20p13 and Duplication of 20p13p12.3 in a Patient with Delayed Speech and Development. Ann Lab Med. 2017; 38(1):77-79. PMC: 5700154. DOI: 10.3343/alm.2018.38.1.77. View

17.

Zilina O, Teek R, Tammur P, Kuuse K, Yakoreva M, Vaidla E . Chromosomal microarray analysis as a first-tier clinical diagnostic test: Estonian experience. Mol Genet Genomic Med. 2014; 2(2):166-75. PMC: 3960059. DOI: 10.1002/mgg3.57. View

18.

Battaglia A, Doccini V, Bernardini L, Novelli A, Loddo S, Capalbo A . Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. Eur J Paediatr Neurol. 2013; 17(6):589-99. DOI: 10.1016/j.ejpn.2013.04.010. View

19.

Kramer J, van Bokhoven H . Genetic and epigenetic defects in mental retardation. Int J Biochem Cell Biol. 2008; 41(1):96-107. DOI: 10.1016/j.biocel.2008.08.009. View

20.

Di Gregorio E, Riberi E, Belligni E, Biamino E, Spielmann M, Ala U . Copy number variants analysis in a cohort of isolated and syndromic developmental delay/intellectual disability reveals novel genomic disorders, position effects and candidate disease genes. Clin Genet. 2017; 92(4):415-422. DOI: 10.1111/cge.13009. View